Engineered primate cystine/cysteine degrading enzymes as antineogenic agents
AssigneeBoard of Regents, The University of Texas System
InventorsGeorge Georgiou, Everett Stone
Life of this patent
Estimating the term…
Abstract
Methods and compositions related to the engineering of a protein with L-cyst(e)ine degrading enzyme activity are described. For example, in certain aspects there may be disclosed a modified cystathionine-γ-lyase comprising one or more amino acid substitutions and capable of degrading L-cyst(e)ine. Furthermore, certain aspects of the invention provide compositions and methods for the treatment of cancer with L-cyst(e)ine using the disclosed proteins or nucleic acids.
Claims12
An isolated, modified primate cystathionine-γ-lyase (CGL) enzyme having at least one substitution relative to a native primate CGL amino acid sequence (see SEQ ID NOs:
- 1 and 7-10), said at least one substitution including a threonine at position 59 of the native primate CGL sequence.
An isolated, modified primate cystathionine-γ-lyase (CGL) enzyme having at least two substitutions relative to a native primate CGL amino acid sequence (see SEQ ID NOs:
- 1 and 7-10), said at least two substitutions including a threonine at position 59 and a valine at position 339 of the native primate CGL sequence.
Dependencies are inferred from the claim text.